Delivery Order SPE2DB20D1100-SPE2DB24FB9L4
Award Date
5/23/24
Potential Completion Date
5/24/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,134.91 firm fixed-price contract is for the delivery of 4567021601 XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,307.07 firm fixed-price delivery order is for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,181.49 firm fixed-price delivery order is for the pharmaceutical product XCOPRI 100 MG TABLET 30S, with a completion date of April 24, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of the pharmaceutical product XCOPRI 100 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract, valued at $3,248.19, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product XCOPRI 100 MG TABLET 30S. The award, valued at $3,310.06, is a firm fixed-price delivery order contract issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 11, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, is the prime contractor and has an...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XCOPRI 100 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price contract, valued at $3,661.94, has a completion date of June 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,147.52 firm fixed-price delivery order contract is for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XCOPRI 200 MG TABLET 30S. The $2,693.21 Firm Fixed Price contract was awarded on April 26, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of April 29, 2024. This appears to be a stand-alone delivery order contract, as no set-aside designation is mentioned. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $6,672.49 and runs through November 15, 2023. The contract is a firm fixed-price, delivery order type. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 Firm Fixed Price Delivery Order covers the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has a completion date of February 4, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...